Extraction and Evaluation of Nutraceutical Molecules in Wastes of Fruit and Vegetables
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TERPENES and FLAVONOIDS from SALVIA APIANA and THEIR AFFINITIES to CANNABINOID and OPIOID RECEPTORS By: Taylor Hayes a Thesis Su
TERPENES AND FLAVONOIDS FROM SALVIA APIANA AND THEIR AFFINITIES TO CANNABINOID AND OPIOID RECEPTORS By: Taylor Hayes A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College Oxford, MS May 2016 Approved by _________________________ Advisor: Dr. Samir A. Ross _________________________ Reader: Dr. Stephen J. Cutler _________________________ Reader: Dr. John M. Rimoldi © 2016 Taylor Josephine Hayes ALL RIGHTS RESERVED ii ACKNOWLEDGEMENTS I first want to thank my advisor, Dr. Samir A. Ross, and Dr. Sri Vedavyasa Sri Radhakrishnan for their guidance and encouragement. I am very thankful for Dr. Ross allowing me to work with in his lab in order to complete this process. I am extremely thankful for Dr. Radhakrishnan for the countless hours he has devoted to teaching me about the process of research and scientific writing. I would not have been able to finish this project without their support. Thank you to Dr. Stephen J. Cutler and Dr. John M. Rimoldi for serving as readers for this thesis. It would not have been possible without their input and willingness to help out. All of this Research was made possible by the Institutional Development Award (IDeA) Grant Number P20GM104932 from the National Institute of General Medical Sciences (NIGMS) and the Center of Research Excellence in Natural Products Neuroscience at the University of Mississippi. I would also like to thank the Sally McDonnell Barksdale Honors College for giving me the opportunity and the push that I needed take on a thesis. Dr. John Samonds was very helpful in answering all of my questions and concerns through this process. -
(H1N1) Neuraminidase Protein by Molecular Docking
eISSN 2234-0742 Genomics Inform 2016;14(3):96-103 G&I Genomics & Informatics http://dx.doi.org/10.5808/GI.2016.14.3.96 ORIGINAL ARTICLE Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking Maheswata Sahoo1, Lingaraja Jena1, Surya Narayan Rath2, Satish Kumar1* 1Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India 2Department of Bioinformatics, Orissa University of Agriculture & Technology, Bhubaneswar 751003, India The influenza A (H1N1) virus, also known as swine flu is a leading cause of morbidity and mortality since 2009. There is a need to explore novel anti-viral drugs for overcoming the epidemics. Traditionally, different plant extracts of garlic, ginger, kalmegh, ajwain, green tea, turmeric, menthe, tulsi, etc. have been used as hopeful source of prevention and treatment of human influenza. The H1N1 virus contains an important glycoprotein, known as neuraminidase (NA) that is mainly respon- sible for initiation of viral infection and is essential for the life cycle of H1N1. It is responsible for sialic acid cleavage from glycans of the infected cell. We employed amino acid sequence of H1N1 NA to predict the tertiary structure using Phyre2 server and validated using ProCheck, ProSA, ProQ, and ERRAT server. Further, the modelled structure was docked with thirteen natural compounds of plant origin using AutoDock4.2. Most of the natural compounds showed effective inhibitory activity against H1N1 NA in binding condition. This study also highlights interaction of these natural inhibitors with amino residues of NA protein. Furthermore, among 13 natural compounds, theaflavin, found in green tea, was observed to inhibit H1N1 NA proteins strongly supported by lowest docking energy. -
Bright” Future?
UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” DIPARTIMENTO DI SCIENZE DEL FARMACO Dottorato di Ricerca in Chemistry and Biology XXXI cycle PENTACYCLIC TRITERPENIC ACIDS AS MODULATORS OF TRANSCRIPTION FACTORS: OLD SCAFFOLDS WITH A “BRIGHT” FUTURE? Federica Rogati Supervised by Prof. Alberto Minassi Ph.D program co-ordinator Prof. Guido Lingua UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” DIPARTIMENTO DI SCIENZE DEL FARMACO Dottorato di Ricerca in Chemistry and Biology XXXI cycle PENTACYCLIC TRITERPENIC ACIDS AS MODULATORS OF TRANSCRIPTION FACTORS: OLD SCAFFOLDS WITH A “BRIGHT” FUTURE? Federica Rogati Supervised by Prof. Alberto Minassi Ph.D program co-ordinator Prof. Guido Lingua ai miei Nonni, ai miei angeli “una nave è al sicuro nel porto, ma questo non è il posto per cui le navi sono fatte” William G.T Shedd ~ CONTENTS ~ Preface 1 CHAPTER 1: DEOXYGENATION OF URSOLIC, OLEANOLIC AND 9 BETULINIC ACID TO THEIR CORRESPONDING C-28 METHYL DERIVATIVES (α-AMYRIN, β-AMYRIN, LUPEOL) 1.1 Introduction 10 1.2 Rationale of the project 13 1.3 Results and discussion 15 1.3.1 Chemistry 15 1.3.2 Biological evaluation 19 1.3.3 Conclusions 19 1.4 Experimental section 20 1.5 Bibliography 25 CHAPTER 2: TRITERPENOID HYDROXAMATES AS HIF PROLYL 27 HYDROLASE INHIBITORS 2.1 Introduction 28 2.2 Rationale of the project 32 2.3 Results and discussion 33 2.3.1 Chemistry 33 2.3.2 Biological evaluation 46 2.3.3 Conclusions 61 2.4 Experimental section 62 i 2.5 Bibliography 76 CHAPTER 3: STRIGOTERPENOIDS, A CLASS OF CROSS-KINGDOM 81 STRESS RESPONSE MODULATORS 3.1 Introduction 82 3.2 Rationale of the project 90 3.3 Results and discussion 94 3.3.1 Chemistry 94 3.3.2 Biological evaluation 101 3.3.3 Conclusions 104 3.4 Experimental section 105 3.5 Bibliography 118 CHAPTER 4: SYNTHESIS OF 1,2,3- TRIAZOLE ANALOGUES OF 121 ANTI-HIV DRUG BEVIRIMAT 4.1 Introduction 122 4.2 Rationale of the project 131 4.3 Results and discussion 132 4.3.1 Chemistry 132 4.3.2 Conclusions 139 4.4 Experimental section 140 4.5 Bibliography 151 5. -
Extraction of High Value Triterpenic Acids from Eucalyptus Globulus Biomass Using Hydrophobic Deep Eutectic Solvents
molecules Article Extraction of High Value Triterpenic Acids from Eucalyptus globulus Biomass Using Hydrophobic Deep Eutectic Solvents Nuno H. C. S. Silva , Eduarda S. Morais, Carmen S. R. Freire, Mara G. Freire and Armando J. D. Silvestre * CICECO-Aveiro Institute of Materials, Chemistry Department, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal; [email protected] (N.H.C.S.S.); [email protected] (E.S.M.); [email protected] (C.S.R.F.); [email protected] (M.G.F.) * Correspondence: [email protected] Academic Editor: Mert Atilhan Received: 9 December 2019; Accepted: 31 December 2019; Published: 4 January 2020 Abstract: Triterpenic acids (TTAs), known for their promising biological properties, can be found in different biomass sources and related by-products, such as Eucalyptus globulus bark, and have been extracted using organic volatile solvents such as dichloromethane. Recently, deep eutectic solvents (DES) have been identified as promising alternatives for the extraction of value-added compounds from biomass. In the present work, several hydrophobic DES were tested for the extraction of TTAs from E. globulus bark. Initial solubility studies revealed that DES based on menthol and thymol as the most promising solvents for these compounds given the highest solubilities obtained for ursolic acid (UA) at temperatures ranging from room temperature up to 90 ◦C. Accordingly, an eutectic mixture of menthol:thymol (1:2) was confirmed as the best candidate for the TTAs extraction from E. globulus outer bark, leading to extraction yields (weight of TTA per weight of biomass) at room temperature of 1.8 wt% for ursolic acid, 0.84 wt% for oleanolic acid and 0.30 wt% for betulinic acid. -
Discovery of Anti-2019-Ncov Agents from 38 Chinese Patent Drugs
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 23 February 2020 doi:10.20944/preprints202002.0254.v2 Discovery of anti-2019-nCoV agents from 38 Chinese patent drugs toward respiratory diseases via docking screening Yong-Ming Yan1,†, Xin Shen2,†, Yong-Kai Cao1, Jiao-Jiao Zhang1, Yan Wang2,*, Yong-Xian Cheng1,* 1 School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen 518060, P.R. China 2 Center for Translation Medicine Research and Development, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P.R. China * To whom correspondence should be addressed: Tel: 86755-2690 2073; E-mail: [email protected] (Y.-X. C.); 86755-2641 7985; E-mail: [email protected] (Y. W.) † These authors contributed equally to this paper. Running Title: Natural agents against 2019-nCoV by docking screening Keywords: 2019-nCoV, novel coronavirus pneumonia, docking, ACE2, viral main protease © 2020 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 23 February 2020 doi:10.20944/preprints202002.0254.v2 Abstract The 2019 novel coronavirus (2019-nCoV) causes novel coronavirus pneumonia (NCP). Given that approved drug repurposing becomes a common strategy to quickly find antiviral treatments, a collection of FDA-approved drugs can be powerful resources for new anti-NCP indication discoveries. In addition to synthetic compounds, Chinese Patent Drugs (CPD), also play a key role in the treatment of virus related infections diseases in China. Here we compiled major components from 38 CPDs that are commonly used in the respiratory diseases and docked them against two drug targets, ACE2 receptor and viral main protease. -
Ursolic Acid Prevents Augmented Peripheral Inflammation and Inflammatory Hyperalgesia in High-Fat Diet-Induced Obese Rats by Restoring Downregulated Spinal Pparα
MOLECULAR MEDICINE REPORTS 13: 5309-5316, 2016 Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPARα YANAN ZHANG1, CHENGWEI SONG1, HAIOU LI1, JINGDONG HOU1 and DONGLIANG LI2 1Department of Anesthesiology, Jining First People's Hospital, Jining, Shandong 272011; 2Department of Anesthesiology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China Received June 7, 2015; Accepted April 2, 2016 DOI: 10.3892/mmr.2016.5172 Abstract. Obesity is a risk factor for several pain syndromes inhibited the exaggerated spinal cord inflammatory response and is associated with increased pain sensitivity. Evidence to peripheral inflammatory stimulation in HFD-induced suggests that obesity causes the downregulation of peroxi- obesity by restoring downregulated spinal PPARα, preventing some proliferator-activated receptor (PPAR)α in the spinal peripheral inflammation and inflammatory hyperalgesia. UA cord, contributing to augmented peripheral edema and may be a potential therapeutic option for the prevention of inflammatory hyperalgesia. Ursolic acid (UA), a natural increased inflammatory pain in obese patients. pentacyclic triterpenoid carboxylic acid, has been shown to upregulate PPARα in the peripheral tissues of obese animals. Introduction The present study hypothesized that UA prevents augmented peripheral inflammation and inflammatory hyperalgesia The rise in global obesity rates over the last three decades has in obesity by restoring downregulated spinal PPARα. The been substantial and widespread, becoming a major public present study demonstrated that Sprague-Dawley rats fed health epidemic in developed and developing countries (1-3). a high-fat diet (HFD) for 12 weeks developed obesity and Obesity is also well-recognized as a risk factor associated metabolic disorder. -
(12) United States Patent (10) Patent No.: US 7431,948 B2 Tripp Et Al
USOO743 1948B2 (12) United States Patent (10) Patent No.: US 7431,948 B2 Tripp et al. (45) Date of Patent: Oct. 7, 2008 (54) COMPOSITIONS THAT TREAT OR INHIBIT 4,154,865 A 5, 1979 Grant PATHOLOGICAL CONDITIONS 4,170,638 A 10, 1979 Owades ASSOCATED WITH INFLAMMATORY 4.389,421 A 6, 1983 Palamand RESPONSE 4,401.684 A 8/1983 Versluys 4473,551 A 9/1984 Schinitsky 4,554,170 A 11/1985 Panzer et al. (75) Inventors: Matthew L. Tripp, Gig Harbor, WA 4,644,084 A 2f1987 Cowles et al. (US); John G. Babish, Brooktondale, 4,692.280 A 9/1987 Spinelli NY (US); Jeffrey S. Bland, Fox Island, 4,767,640 A 8, 1988 Goldstein et al. WA (US); Gary K. Darland, Gig 4,822,607 A * 4, 1989 Balassa et al. .............. 424,548 Harbor, WA (US); Robert Lerman, Gig 4,857,554 A 8, 1989 Kallimanis Harbor, WA (US); Daniel O. Lukaczer, 5,006,337 A 4, 1991 Motitschke et al. Gig Harbor, WA (US); DeAnn J. Liska, 5,013,571 A 5/1991 Hay Tacoma, WA (US); Terrence Howell, 5,041,300 A 8, 1991 Todd et al. Lansing, NY (US) 5,073,396 A 12/1991 Todd, Jr. 5,082,975 A 1/1992 Todd, Jr. et al. 5,155,276 A 10, 1992 Paul (73) Assignee: Metaproteomics, LLC, San Clemente, 5,166,449 A 1 1/1992 Todd, Jr. et al. CA (US) 5,264,236 A 11/1993 Ogasahara et al. 5,286,506 A 2f1994 Millis et al. (*) Notice: Subject to any disclaimer, the term of this 5,296,637 A 3/1994 Stegink et al. -
Health and Nutrition
ABSTRACTS 2019 AOCS ANNUAL MEETING & EXPO May 5–8, 2019 HEALTH AND NUTRITION H&N 1: Lipids and Inflammation Chair: Eric Murphy, University of North Dakota, USA Increase in Plasma Ganglioside Content is significant effect of ganglioside on bowel Associated with Improved Quality of Life in symptoms or social function. Inflammatory Bowel Disease John J. Conclusions. Daily consumption of Miklavcic*1, Glen Shoemaker2, Kareena L. ganglioside increases plasma ganglioside Schnabl3, Alan BR Thomson4, Vera Mazurak2, concentration and constitutes a viable agent for and M Tom Clandinin5,1Chapman University, treatment of IBD or for potential treatment of USA; 2University of Alberta, Canada; other disorders in which altered ganglioside 3Laboratory Medicine and Pathology, University content has been implicated. of Alberta, Canada; 4Gastroenterology, Western University, Canada; 5Centre for Health and FABP1 and Its Emerging Role in Systemic Nutrition, University of Alberta, Canada and Brain Endocannabinoid Systems. Eric Dietary ganglioside has been shown to Murphy, University of North Dakota, USA decrease inflammation, improve gut-barrier Pending. function, and prevent infection by pathogenic micro-organisms. Are Oxidized Linoleic Acid Metabolites Objective. To determine if dietary Bioavailable? Ameer Taha*, University of ganglioside is bioavailable in human California, Davis, USA participants and whether ganglioside consumption improves clinical outcomes in Background: Omega-6 linoleic acid (LA, 18:2n-6) inflammatory bowel disease (IBD). is a precursor to oxidized linoleic acid Methods Used. Healthy control participants metabolites (OXLAMs) which regulate multiple and patients with IBD were recruited for a biological processes. In vivo, OXLAMs can be double-blind, randomized, placebo-controlled synthesized enzymatically or non-enzymatically study. Participants were allocated to receive from LA. -
Metabolomic Profile and Cytotoxic Activity of Cissus Incisa Leaves
plants Article Metabolomic Profile and Cytotoxic Activity of Cissus incisa Leaves Extracts Deyani Nocedo-Mena 1,*, María Yolanda Ríos 2 , M. Ángeles Ramírez-Cisneros 2 , Leticia González-Maya 3 , Jessica N. Sánchez-Carranza 3 and María del Rayo Camacho-Corona 1,* 1 Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Av. Universidad S/N, Ciudad Universitaria, San Nicolás de los Garza 66451, Nuevo León, Mexico 2 Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Cuernavaca 62209, Morelos, Mexico; [email protected] (M.Y.R.); [email protected] (M.Á.R.-C.) 3 Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Cuernavaca 62209, Morelos, Mexico; [email protected] (L.G.-M.); [email protected] (J.N.S.-C.) * Correspondence: [email protected] (D.N.-M.); [email protected] (M.d.R.C.-C.); Tel.: +52-81-22-01-3777 (D.N.-M.); +52-81-8329-4000 (ext. 3414) (M.d.R.C.-C.) Abstract: Cissus incisa leaves have been traditionally used in Mexican traditional medicine to treat certain cancerous illness. This study explored the metabolomic profile of this species using untargeted technique. Likewise, it determined the cytotoxic activity and interpreted all data by computational tools. The metabolomic profile was developed through UHPLC-QTOF-MS/MS for dereplication pur- Citation: Nocedo-Mena, D.; Ríos, poses. MetaboAnalyst database was used in metabolic pathway analysis and the network topological M.Y.; Ramírez-Cisneros, M.Á.; analysis. Hexane, chloroform/methanol, and aqueous extracts were evaluated on HepG2, Hep3B, González-Maya, L.; HeLa, PC3, A549, and MCF7 cancer cell lines and IHH immortalized hepatic cells, using Cell Titer Sánchez-Carranza, J.N.; proliferation assay kit. -
Molecular Mechanisms of Cannabinoids As Anti
MOLECULAR MECHANISMS OF CANNABINOIDS AS ANTI- CANCER AGENTS A Dissertation by SANDEEP SREEVALSAN Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Stephen H. Safe Committee Members, Robert C. Burghardt Yanan Tian Weston Porter Intercollegiate Faculty Chair, Weston Porter August 2013 Major Subject: Toxicology Copyright 2013 Sandeep Sreevalsan ABSTRACT Cancer is a growing health concern world-wide and is the second most common cause of death after heart diseases. Current treatment strategies such as surgery, chemotherapy and radiation provide some relief to cancer patients but the toxic side effects associated with chemotherapy and radiation often lead to further adverse health effects. Hence there is a need for drugs with better safety profile and improved efficacy. Cannabinoids are a group of compounds with several therapeutic properties and besides their appetite stimulant, anti-emetic and analgesic effects, cannabinoids can inhibit tumor growth, survival and metastasis. The mechanisms of action of cannabinoids as anticancer agents are highly complex and not completely understood. Studies from our laboratory indicate that the specificity protein (Sp) transcription factors, Sp1, Sp3 and Sp4 that belong to the Sp/KLF family of transcription factors are overexpressed in many tumors and regulate critical factors responsible for cancer cell proliferation, growth, angiogenesis and survival. Hence, we hypothesized that cannabinoids elicit their responses on cancer cells by downregulating the expression of Sp proteins and Sp- regulated gene products. Treatment of colon and prostate cancer cells with the cannabinoids WIN and cannabidiol (CBD) inhibited cancer cell proliferation, induced apoptosis and downregulated Sp proteins and Sp-dependent genes. -
Bioactivities of Eriobotrya Japonica (Thunb.) Lindl
ognosy & ac N m a r t a u h r a P l f P Journal of o r l o a d n u r c Uto et al., J Pharmacogn Nat Prod 2017, 3:1 u t s o J Pharmacognosy & Natural Products DOI: 10.4172/2472-0992.1000134 ISSN: 2472-0992 Review Article Open Access Bioactivities of Eriobotrya japonica (Thunb.) Lindl. Leaf and Its Triterpenes Takuhiro Uto, Nguyen Huu Tung, Kensuke Nakajima, Tomoe Ohta, Shigeru Oiso, Hiroko Kariyazono and Yukihiro Shoyama* Department of Pharmacognosy, Nagasaki International University, Japan *Corresponding author: Yukihiro Shoyama, Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan, Tel: +81-956205740; E-mail: [email protected] Received date: Mar 10, 2017; Accepted date: Mar 25, 2017; Published date: Mar 28, 2017 Copyright: © 2017 Shoyama Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract The dried leaves of Eriobotrya japonica have traditionally been widely used to treat various diseases, such as chronic bronchitis, cough, inflammation, skin disease, and diabetes. Our previous studies have reported several functions and their molecular mechanisms of E. japonica leaf extract and triterpenes contained in the extract. In this review article, we focus on the effects of E. japonica leaf extract and triterpenes on inflammatory mediators, proliferation of cancer cells, and ghrelin production. 1) The leaf extract of E. japonica suppressed inflammatory mediators including nitric oxide (NO) and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-stimulated RAW264 murine macrophage cells. -
Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential
International Journal of Molecular Sciences Review Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential Evelina Gudoityte 1,2, Odeta Arandarcikaite 1, Ingrida Mazeikiene 3 , Vidmantas Bendokas 3,* and Julius Liobikas 1,4,* 1 Laboratory of Biochemistry, Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania; [email protected] (E.G.); [email protected] (O.A.) 2 Celignis Limited, Unit 11 Holland Road, Plassey Technology Park Castletroy, County Limerick, Ireland 3 Lithuanian Research Centre for Agriculture and Forestry, Institute of Horticulture, Akademija, LT-58344 Kedainiai Distr., Lithuania; [email protected] 4 Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania * Correspondence: [email protected] (V.B.); [email protected] (J.L.) Abstract: Ursolic and oleanolic acids are secondary plant metabolites that are known to be involved in the plant defence system against water loss and pathogens. Nowadays these triterpenoids are also regarded as potential pharmaceutical compounds and there is mounting experimental data that either purified compounds or triterpenoid-enriched plant extracts exert various beneficial effects, including anti-oxidative, anti-inflammatory and anticancer, on model systems of both human or animal origin. Some of those effects have been linked to the ability of ursolic and oleanolic acids to modulate intracellular antioxidant systems and also inflammation and cell death-related pathways. Therefore, our aim was to review current studies on the distribution of ursolic and oleanolic acids in plants, bioavailability and pharmacokinetic properties of these triterpenoids and their derivatives, Citation: Gudoityte, E.; and to discuss their neuroprotective effects in vitro and in vivo.